By
Drug Target Review2025-07-28T08:30:15
Researchers in China have developed a next-generation CAR-T cell therapy armed with nanogels that can penetrate the dense barriers of solid tumours. This addresses a major limitation in the treatment of solid cancers with immunotherapy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-20T13:00:00Z
2026-11-20T08:00:00Z
Contributor Dr Rahul Gupta, By Drug Target Review
2026-11-18T11:12:00Z
2026-08-17T14:16:00
Contributor Dr Rab Prinjha, By Drug Target Review
2026-10-01T06:30:00
Sponsored by Promega Corporation
2026-06-15T07:00:00
Contributor Professor Dipak Ramji, By Drug Target Review
2023-03-20T13:41:33
Sponsored by Bio-Techne
2025-05-28T14:00:00
Sponsored by Eurofins DiscoverX
2023-03-28T11:38:32
Sponsored by Bio-Techne
Site powered by Webvision Cloud